EICHORCondition: Stage IIIB Lung Non-Small Cell Cancer AJCC v7 · Stage IV Non-Small Cell Lung Cancer AJCC v7 · Sponsor: National Cancer Institute (NCI)
This randomized phase III trial studies sunitinib malate to see how well it works when given as maintenance therapy (meaning it is approved for treatment after chemotherapy) in patients with stage IIIB-IV non-small cell lung cancer who have responded to prior treatment with combination chemotherapy. Sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking the growth of new blood vessels necessary for tumor growth. It is not yet known whether sunitinib malate is effective in helping tumors continue to shrink or stop growing.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Northeast Alabama Regional Medical Center | Anniston, Alabama, United States | — |
| Providence Hospital | Mobile, Alabama, United States | — |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| Veteran's Administration Medical Center | Little Rock, Arkansas, United States | — |
| Kaiser Permanente-Anaheim | Anaheim, California, United States | — |
| PCR Oncology | Arroyo Grande, California, United States | — |
| Kaiser Permanente-Baldwin Park | Baldwin Park, California, United States | — |
| Kaiser Permanente-Bellflower | Bellflower, California, United States | — |
| East Bay Radiation Oncology Center | Castro Valley, California, United States | — |
| Eden Hospital Medical Center | Castro Valley, California, United States | — |
| Valley Medical Oncology Consultants-Castro Valley | Castro Valley, California, United States | — |
| Feather River Cancer Center | Chico, California, United States | — |
+ 472 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00693992